ArticleCanadian Urological Association journal = Journal de l'Association des urologues du Canada2026
Development of a preoperative risk prediction model of muscle-invasive upper tract urothelial carcinoma using clinical and radiomic computed tomography features Initial results from a multi-institutional, Canadian study.
Article in Canadian Urological Association journal = Journal de l'Association des urologues du Canada, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionAccurate pre-intervention staging of upper tract urothelial carcinoma (UTUC) remains a significant clinical challenge, particularly in identifying muscle-invasive disease (≥pT2), where kidney-sparing surgery may not be appropriate. Current imaging and biopsy approaches are often inadequate. Radiomics, which extracts high-dimensional features from medical imaging, may improve non-invasive staging. This study assessed whether computed tomography (CT)-based radiomic features, alone or combined with clinical data, could predict ≥pT2 UTUC in a multicenter Canadian cohort.
methodsWe retrospectively analyzed clinical, pathologic, and radiographic features of patients with UTUC who underwent extirpative surgery at five academic centers from January 2, 2001, to May 1, 2023. Radiomic features were extracted from machine-learning segmentations of the affected kidney using the excretory phase of CT. Predictive models were developed using clinical-only, radiomic-only, and combined data to predict stage ≥pT2. Feature selection included univariable logistic regression, correlation filtering, and LASSO. Model performance was assessed via five-fold cross-validation repeated 10 times, with area under the curve (AUC) as the primary metric.
resultsOf 441 patients, 208 (47.2%) were included. Of the 208 patients, 97 (46.6%) had ≥pT2 disease. The clinical model (AUC 0.602) included age, hydronephrosis, and high-grade cytology. The radiomics model, based on two texture features, achieved an AUC of 0.653. The combined model achieved an AUC of 0.647. Radiomics and combined models significantly outperformed the clinical model (p<0.01), but did not differ from each other. For 117 patients with renal pelvis cancers, the combined model's discrimination performance was statistically better than the clinical model (AUC 0.708 vs. AUC 0.607, p<0.001). Likewise, the radiomics' AUC discrimination performance was statistically better than the clinical model (AUC 0.694 vs. AUC 0.607, p=0.004). In contrast, we found no significant difference in model performance in the non-renal pelvis subgroup (n=91).
conclusionsConventional radiomics improved the prediction of muscle-invasive UTUC compared to clinical models alone, but overall accuracy remained suboptimal for clinical use. Heterogeneity in CT protocols and challenges with tumor segmentation were the main limitations. Future work should develop more adaptable AI models trained on larger, more diverse datasets to better reflect real-world imaging conditions.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.